French pharma Amolyt nets €130 million series C co-led by Sofinnova Partners
HQ: FR
Founded: 2015
Series C
Sector: Health Care
Investment Raised: EUR 130M €
Valuation Remains Undisclosed
Investors: Andera Partners (https://www.anderapartners.com/fr/) ATEM Capital Fund LP (https://atemcap.com/) Bpifrance (https://www.bpifrance.com/) Credit Agricole Entreprises (https://www.credit-agricole.fr/entreprise.html) CTI Life Sciences Fund (https://www.ctisciences.com/) EQT life science (https://eqtgroup.com/) Intermediate Capital Group (https://www.icgam.com/) Kurma Partners (https://www.kurmapartners.com/en) Mass General Brigham Ventures (https://www.massgeneralbrigham.org/en/research-and-innovation/innovation/ventures) Novo Ventures (https://www.novoholdings.dk/investments/ventures/) OrbiMed (https://www.orbimed.com/) Pontifax (http://www.pontifax.com/) Sectoral Asset Management (https://www.sectoral.com/) Sofinnova Partners (https://sofinnovapartners.com/) Tekla Capital Management (https://www.teklacap.com/) Turenne Capital (https://www.turennecapital.com/)
Opna Bio Launches with $38 Million Series A Financing to Advance Novel Oncology Discovery Program and Diversified Pipeline of Clinical and Preclinical Programs
HQ: CH
Founded: 2019
Series A
Sector: Health Care
Investment Raised: USD 38M €
Valuation Remains Undisclosed
Investors: Longitude Capital (https://www.longitudecapital.com/) Menlo Ventures (https://www.menlovc.com/) Northpond Ventures (https://www.npv.vc/)
Ochre Bio Raises $30M Series A Financing for the Development of RNA Therapies for Chronic Liver Diseases
HQ: UK
Founded: 2019
Series A
Sector: Health Care
Investment Raised: USD 30M €
Valuation Remains Undisclosed
Investors: AixThera (https://www.aixthera.com/) Alice Zhang BACKED VC (https://www.backed.vc/) EIT Health (https://eithealth.eu/) Hermes-Epitek (https://www.hermes-epitek.com.sg/) Khosla Ventures (https://www.khoslaventures.com/) Kristen Fortney Lifeforce Capital (https://www.lifeforcecap.com/) LifeLink Ventures (https://www.lifelinkventures.com/) Martin Chavez Selvedge Venture (https://www.selvedgeventure.com/)